Abstract
Purpose
To review experience and indications for head and neck (HN) tumors at our center in relation to the published literature.
Methods
HN cancer patients treated at our center either with protons (PT) or carbon ions (CIRT) were extracted from our institutional retrospective and longitudinal Registry (NCT05203250 REGAL), including all the patients treated since the beginning of our clinical activity. A literature search was conducted with selection of most representative published studies for adenoid cystic carcinoma (ACC), mucosal melanoma (MM), sinonasal cancers (SNCs) and reirradiations.
Results
Since the beginning of the clinical activity in 2011, 1311 HN tumors have been treated a tour center. Majority of treated patients were ACC (52%), non-ACC salivary gland tumors (18%), paranasal sinuses tumors (9%), MM (7%), and reirradiation of recurrent tumors after previous RT (14%). Oncological outcome in terms of safety and efficacy has been published on the series of 184 ACC and 40 MM, both treated with CIRT in the years 2013–2020. Reviewed reirradiation published series included a cohort of 52 recurrent salivary gland tumors retreated with CIRT from 2013 to 2016, and the experience of 2013–2020 of retreatment of 15 SNCs (13 with CIRT and 2 with PT).
Conclusion
HN tumors are major indications for particle treatment around the world and at our center. Particle treatment might be personalized for each patient, with CIRT indicated for radioresistant tumors such as ACC and MM. Data on oncologic outcomes of CIRT at our center are consistent with published series.
Similar content being viewed by others
Data availability statement
Requests to the corresponding author will follow internal procedures according to the center ethic and privacy policy.
Reference
Orlandi E, Barcellini A, Vischioni B, Fiore MR, Vitolo V, Iannalfi A, Bonora M, Chalaszczyk A, Ingargiola R, Riva G, Ronchi S, Valvo F, Fossati P, Ciocca M, Mirandola A, Molinelli S, Pella A, Baroni G, Pullia MG, Facoetti A, Orecchia R, Licitra L, Vago G, Rossi S. The Role of Carbon Ion Therapy in the Changing Oncology Landscape-A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy. Cancers (Basel). 2023;15(20):5068. https://doi.org/10.3390/cancers15205068.
Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel). 2020;12(10):3022. https://doi.org/10.3390/cancers12103022.
Loap P, Vischioni B, Bonora M, Ingargiola R, Ronchi S, Vitolo V, Barcellini A, Goanta L, De Marzi L, Dendale R, Pacelli R, Locati L, Calugaru V, Mammar H, Cavalieri S, Kirova Y, Orlandi E. Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review. Front Oncol. 2021;30(11):789079. https://doi.org/10.3389/fonc.2021.789079.
Barcellini A, Vitolo V, Facoetti A, Fossati P, Preda L, Fiore MR, Vischioni B, Iannalfi A, Bonora M, Ronchi S, D’Ippolito E, Petrucci R, Viselner G, Ciocca M, Valvo F, Orecchia R. Feasibility of Carbon Ion Radiotherapy in the Treatment of Gynecological Melanoma. In Vivo. 2009;33(2):473–6. https://doi.org/10.21873/invivo.11497.
Jensen AD, Poulakis M, Nikoghosyan AV, Welzel T, Uhl M, Federspil PA, Freier K, Krauss J, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years’ experience with raster-scanned carbon ion therapy. Radiother Oncol. 2016;118(2):272–80. https://doi.org/10.1016/j.radonc.2015.05.010.
Locati LD, Ferrarotto R, Licitra L, Benazzo M, Preda L, Farina D, Gatta G, Lombardi D, Nicolai P, Vander Poorten V, Chua MLK, Vischioni B, Sanguineti G, Morbini P, Fonseca I, Sozzi D, Merlotti A, Orlandi E. Current management and future challenges in salivary glands cancer. Front Oncol. 2023;19(13):1264287. https://doi.org/10.3389/fonc.2023.1264287.
Orlandi E, Iacovelli NA, Bonora M, Cavallo A, Fossati P. Salivary Gland: Photon beam and particle radiotherapy: Present and future. Oral Oncol. 2016;60:146–56. https://doi.org/10.1016/j.oraloncology.2016.06.019.
Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26(2):154–62. https://doi.org/10.1002/hed.10380.
Laramore GE, Krall JM, Griffin TW, Duncan W, Richter MP, Saroja KR, Maor MH, Davis LW. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group, Medical Research Council. Int J Radiat Oncol Biol Phys. 1993;27(2):235–40. https://doi.org/10.1016/0360-3016(93)90233-l.
Sulaiman NS, Demizu Y, Koto M, Saitoh JI, Suefuji H, Tsuji H, Ohno T, Shioyama Y, Okimoto T, Daimon T, Nemoto K, Nakano T, Kamada T, Japan Carbon-Ion Radiation Oncology Study Group. Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). Int J Radiat Oncol Biol Phys. 2018;100(3):639–46. https://doi.org/10.1016/j.ijrobp.2017.11.010.
Iannalfi A, D’Ippolito E, Riva G, Molinelli S, Gandini S, Viselner G, Fiore MR, Vischioni B, Vitolo V, Bonora M, Ronchi S, Petrucci R, Barcellini A, Mirandola A, Russo S, Vai A, Mastella E, Magro G, Maestri D, Ciocca M, Preda L, Valvo F, Orecchia R. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy. Neuro Oncol. 2020;22(9):1348–58. https://doi.org/10.1093/neuonc/noaa067. Erratum. In: Neuro Oncol. 2022 Aug 1;24(8):1402–1403.
Molinelli S, Bonora M, Magro G, Casale S, Dale JE, Fossati P, Hasegawa A, Mirandola A, Ronchi S, Russo S, Preda L, Valvo F, Orecchia R, Ciocca M, Vischioni B. RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes. Radiother Oncol. 2019;141:227–33. https://doi.org/10.1016/j.radonc.2019.08.022.
Vischioni B, Bonora M, Ronchi S, Ingargiola R, Camarda AM, Molinelli S, Imparato S, Fiorino F, Rancati T, Ciocca M, Orlandi E. OC-0110 Head and neck adenoid cystic carcinoma treated with raster scanning carbon ion radiotherapy at CNAO. Radiother Oncol. 2023;182:S70–1. https://doi.org/10.1016/S0167-8140(23)08524-9.
Wada H, Nemoto K, Ogawa Y, Hareyama M, Yoshida H, Takamura A, Ohmori K, Hamamoto Y, Sugita T, Saitoh M, Yamada S. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys. 2004;59(2):495–500. https://doi.org/10.1016/j.ijrobp.2003.11.013.
Mizoe JE, Hasegawa A, Jingu K, Takagi R, Bessyo H, Morikawa T, Tonoki M, Tsuji H, Kamada T, Tsujii H, Okamoto Y, Organizing Committee for the Working Group for Head Neck Cancer. Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol. 2012;103(1):32–7. https://doi.org/10.1016/j.radonc.2011.12.013.
Yanagi T, Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T, Kamada T, Okamoto Y, Tsujii H. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys. 2009;74(1):15–20. https://doi.org/10.1016/j.ijrobp.2008.07.056.
Koto M, Demizu Y, Saitoh JI, Suefuji H, Tsuji H, Okimoto T, Ohno T, Shioyama Y, Takagi R, Nemoto K, Nakano T, Kamada T, Japan Carbon-Ion Radiation Oncology Study Group. Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). Int J Radiat Oncol Biol Phys. 2017;97(5):1054–60. https://doi.org/10.1016/j.ijrobp.2016.12.028.
Ronchi S, Cicchetti A, Bonora M, Ingargiola R, Camarda AM, Russo S, Imparato S, Castelnuovo P, Pasquini E, Nicolai P, Ansarin M, Del Vecchio M, Benazzo M, Orlandi E, Vischioni B. Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity. Radiother Oncol. 2023;11(190):110003. https://doi.org/10.1016/j.radonc.2023.110003.
Hanaoka Y, Tanemura A, Takafuji M, Kiyohara E, Arase N, Suzuki O, Isohashi F, Ogawa K, Fujimoto M. Local and disease control for nasal melanoma treated with radiation and concomitant anti-programmed death 1 antibody. J Dermatol. 2020;47(4):423–5. https://doi.org/10.1111/1346-8138.15256.
Musha A, Kubo N, Kawamura H, Okano N, Sato H, Okada K, Tomizawa K, Ota N, Adachi A, Shino M, Nikkuni O, Ida S, Shirai K, Saitoh JI, Yokoo S, Chikamatsu K, Ohno T. Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon-ion radiotherapy. Cancer Rep (Hoboken). 2023;6(7):e1825. https://doi.org/10.1002/cnr2.1825.
Cavalieri S, Ronchi S, Barcellini A, Bonora M, Vischioni B, Vitolo V, Villa R, Del Vecchio M, Licitra L, Orlandi E. Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma. Radiother Oncol. 2021;164:1–5. https://doi.org/10.1016/j.radonc.2021.08.021.
Llorente JL, López F, Suárez C, Hermsen MA. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol. 2014;11(8):460–72. https://doi.org/10.1038/nrclinonc.2014.97.
Orlandi E, Cavalieri S, Granata R, Nicolai P, Castelnuovo P, Piazza C, Schreiber A, Turri-Zanoni M, Quattrone P, Miceli R, Infante G, Sessa F, Facco C, Calareso G, Iacovelli NA, Mattavelli D, Paderno A, Resteghini C, Locati LD, Licitra L, Bossi P. Locally advanced epithelial sinonasal tumors: The impact of multimodal approach. Laryngoscope. 2020;130(4):857–65. https://doi.org/10.1002/lary.28202.
Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, Alahdab F, Altayar O, Nabhan M, Schild SE, Foote RL. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014;15(9):1027–38. https://doi.org/10.1016/S1470-2045(14)70268-2.
Ramaekers BL, Pijls-Johannesma M, Joore MA, van den Ende P, Langendijk JA, Lambin P, Kessels AG, Grutters JP. Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons. Cancer Treat Rev. 2011;37(3):185–201. https://doi.org/10.1016/j.ctrv.2010.08.004.
Zhang W, Hu W, Hu J, Gao J, Yang J, Kong L, Lu JJ. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world. Cancer Sci. 2020;111:4465–79.
Resteghini C, Castelnuovo P, Nicolai P, Orlandi E, Bossi P, Vischioni B, Schreiber A, Gambazza S, Iacovelli NA, Battaglia P, Guzzo M, Turri-Zanoni M, Mattavelli D, Facchinetti N, Calareso G, Ravanelli M, Facco C, Tartaro T, Licitra L. The SINTART 1 study: A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours. Eur J Cancer. 2023;187:185–94. https://doi.org/10.1016/j.ejca.2023.03.033.
Bossi P, Orlandi E, Resteghini C, Vischioni B, Nicolai P, Castelnuovo P, Gambazza S, Locati LD, Turri-Zanoni M, Ferrari M, Facchinetti N, Iacovelli NA, Calareso G, Quattrone P, Cavallo A, Tuzi A, Licitra L. The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours. Eur J Cancer. 2023;187:134–43. https://doi.org/10.1016/j.ejca.2023.03.034.
Mirandola A, Russo S, Bonora M, Vischioni B, Camarda AM, Ingargiola R, Molinelli S, Ronchi S, Rossi E, Vai A, Iacovelli NA, Thariat J, Ciocca M, Orlandi E. A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients. Cancers (Basel). 2022;14(11):2678. https://doi.org/10.3390/cancers14112678.
Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN Jr, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. 2016;95(4):1117–31. https://doi.org/10.1016/j.ijrobp.2016.03.015.
Bhattacharyya T, Koto M, Windisch P, Ikawa H, Hagiwara Y, Tsuji H, Adeberg S. Emerging Role of Carbon Ion Radiotherapy in Reirradiation of Recurrent Head and Neck Cancers: What Have We Achieved So Far? Front Oncol. 2022;23(12):888446. https://doi.org/10.3389/fonc.2022.888446.
Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ. Proton Therapy for Head and Neck Cancers. Semin Radiat Oncol. 2018;28(1):53–63. https://doi.org/10.1016/j.semradonc.2017.08.004.
Held T, Windisch P, Akbaba S, Lang K, El Shafie R, Bernhardt D, Plinkert P, Kargus S, Rieken S, Herfarth K, Debus J, Adeberg S. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience. Int J Radiat Oncol Biol Phys. 2019;105(4):803–11. https://doi.org/10.1016/j.ijrobp.2019.07.021.
Vischioni B, Dhanireddy B, Severo C, Bonora M, Ronchi S, Vitolo V, Fiore MR, D’Ippolito E, Petrucci R, Barcellini A, Ciurlia E, Iannalfi A, Hasegawa A, Molinelli S, Mirandola A, Valvo F, Orecchia R. Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO. Radiother Oncol. 2020;145:172–7. https://doi.org/10.1016/j.radonc.2020.01.004.
Hayashi K, Koto M, Ikawa H, Hagiwara Y, Tsuji H, Ogawa K, Kamada T. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy. Radiother Oncol. 2019;136:148–53. https://doi.org/10.1016/j.radonc.2019.04.007.
Gao J, Hu J, Guan X, Yang J, Hu W, Kong L, Lu JJ. Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies. Sci Rep. 2019;9(1):4259. https://doi.org/10.1038/s41598-019-39241-y.
Vischioni B, Ingargiola R, Bonora M, Ronchi S, Camarda AM, Russo S, Rossi E, Magro G, Mirandola A, Orlandi E. Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO. J Clin Med. 2023;12(7):2624. https://doi.org/10.3390/jcm12072624.
Funding
This work has been partly founded by the European Union’s Horizon 2020 Research and Innovation program under grant agreement No 101008548 (HITRIplus).
Author information
Authors and Affiliations
Contributions
Conceptualization: B.V. and E.O.; writing-original draft preparation: B.V.; writing-review and editing: B.V., M.B., S.R. (Sara Ronchi), R.I., A.M.C., S.L., E.R., M.P., S.R. (Stefania Russo), A.M., S.I. and S.M.
Corresponding author
Ethics declarations
Ethical approval
No ethical approval was required for this article.
Consent to participate
No consent to participate was required for this article.
Consent to publish
No consent to publish was required for this article.
Competing interest
The author(s) have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Hadrontherapy and BNCT: Current Status and Future Trends
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vischioni, B., Bonora, M., Ronchi, S. et al. Head and neck cancers: reporting indications and results of hadrontherapy of a dual beam facility. Health Technol. (2024). https://doi.org/10.1007/s12553-024-00843-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12553-024-00843-w